International Society For Bipolar Disorders Research Articles

Impairments in facial expression recognition in patients with euthymic bipolar disorders using the facial emotions recognition test

BackgroundPatients with bipolar disorders (BD) have significant impairments in Facial Expression Recognition (FER), an essential social skill for effective social interactions. While the Facial Emotions Recognition Test, 54 photographs by Gaudelus (TREF-54g) has been used in patients with schizophrenia, no study has evaluated FER using this test in BD patients. The TREF-54g meets the International Society for Bipolar Disorders (ISBD) criteria for assessing FER. The objective of this study was to compare FER in patients with euthymic BD versus healthy controls (HC) using the TREF-54g. MethodsThis study included 60 patients with BD diagnosed according to DSM-5 criteria, 30 with bipolar I disorder (BDI) and 30 with bipolar II disorder (BDII) and 60 HC. All groups were matched for age, gender, and years of education. Overall TREF-54g impairment score was defined as a difference of two SD from the group of HC with mean overall accuracy score expressed as a percentage of correct responses. ResultsOverall TREF-54g impairment scores, as well as sub-scores for anger and contempt recognition, were significantly higher in patients with BD versus those in HC. No significant differences in TREF-54g scores were shown between patients with BDI and those with BDII. LimitationsClinical assessments of this study didn't include neurocognition assessments and classification of contempt emotion as a basic emotion remains controversial. ConclusionsWe found significant impairments in FER in patients with euthymic BD, particularly for anger and contempt using the TREF-54g a test that meets ISBD recommendation criteria.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Supplement: The 26th Annual Conference of the International Society for Bipolar Disorders, Reykjavik, Iceland, 29 September - 1 October 2024.

Fostering networking opportunities and creating a community of early and mid-career clinicians and researchers within the International Society for Bipolar Disorders.

Fostering networking opportunities and creating a community of early and mid-career clinicians and researchers within the International Society for Bipolar Disorders.

The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence.

Bipolar disorder is a complex and heterogeneous psychiatric condition that affects more than 2% of the population. The assessment and treatment of bipolar disorder can be a challenge for clinicians, given its clinical complexity and the rapidly changing treatment landscape with the growing range of treatment options that are becoming available for various phases of the illness. To help clinicians navigate the complexity involved in the assessment and management of bipolar disorder, the guidelines of the 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) synthesized the evidence on the efficacy, safety, and tolerability of treatments for bipolar disorder and translated it into first-, second-, and third-line treatment recommendations. The main objective of this contribution is to provide clinicians with a summary of the 2018 CANMAT/ISBD guideline recommendations with the addition of any new evidence for the treatment of bipolar disorder across the lifespan.

Cognition in Bipolar Disorder: An Update for Clinicians.

Bipolar disorder is associated with cognitive deficits, which persist across mood states and affect functional outcomes. This article provides an overview of recent progress in measuring cognition in bipolar disorder and its implications for both research and clinical practice. The authors summarize work conducted over the past decade that has helped guide researchers and clinicians in the appropriate measurement of cognitive functioning in bipolar disorder, the design of research studies targeting this domain for treatment, and the implementation of screening and psychoeducational tools in the clinic. Much of this work was conducted by the International Society for Bipolar Disorders Targeting Cognition Task Force. Here, the authors also highlight the need for clinicians to be informed about this aspect of illness and to be equipped with the necessary information to assess, track, and intervene on cognitive problems when appropriate. Finally, the article identifies gaps in the literature and suggests potential future directions for research in this area.

Barriers to and facilitators of success for early and Mid-Career professionals focused on bipolar disorder: A global needs survey by the International Society for Bipolar Disorders.

The International Society for Bipolar Disorders created the Early Mid-Career Committee (EMCC) to support career development of the next generation of researchers and clinicians specializing in bipolar disorder (BD). To develop new infrastructure and initiatives, the EMCC completed a Needs Survey of the current limitations and gaps that restrict recruitment and retention of researchers and clinicians focused on BD. The EMCC Needs Survey was developed through an iterative process, relying on literature and content expertise of workgroup members. The survey included 8 domains: navigating transitional career stages, creating and fostering mentorship, research activities, raising academic profile, clinical-research balance, networking and collaboration, community engagement, work-life balance. The final survey was deployed from May to August 2022 and was available in English, Spanish, Portuguese, Italian, and Chinese. Three hundred participants across six continents completed the Needs Survey. Half of the participants self-identified as belonging to an underrepresented group in health-related sciences (i.e., from certain gender, racial, ethnic, cultural, or disadvantaged backgrounds including individuals with disabilities). Quantitative results and qualitative content analysis revealed key barriers to pursuing a research career focused on BD with unique challenges specific to scientific writing and grant funding. Participants highlighted mentorship as a key facilitator of success in research and clinical work. The results of the Needs Survey are a call to action to support early- and midcareer professionals pursuing a career in BD. Interventions required to address the identified barriers will take coordination, creativity, and resources to develop, implement, and encourage uptake but will have long-lasting benefits for research, clinical practice, and ultimately those affected by BD.

ISBD Oral Abstracts

Bipolar DisordersVolume 25, Issue S1 p. 46-55 ABSTRACTS ISBD Oral Abstracts First published: 14 June 2023 https://doi.org/10.1111/bdi.13332Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 46-55 RelatedInformation

Poster Abstracts

Bipolar DisordersVolume 25, Issue S1 p. 56-117 ABSTRACTS Poster Abstracts First published: 14 June 2023 https://doi.org/10.1111/bdi.13333Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 56-117 RelatedInformation

Concurrent State of the Art Abstracts

Bipolar DisordersVolume 25, Issue S1 p. 11-45 ABSTRACT Concurrent State of the Art Abstracts First published: 14 June 2023 https://doi.org/10.1111/bdi.13331Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 11-45 RelatedInformation

Welcome Letter.

Bipolar DisordersVolume 25, Issue S1 p. 7-7 SUPPLEMENT ARTICLE Welcome Letter First published: 14 June 2023 https://doi.org/10.1111/bdi.13337Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 7-7 RelatedInformation

ISBD Keynote Abstracts

Bipolar DisordersVolume 25, Issue S1 p. 9-10 SUPPLEMENT ABSTRACT ISBD Keynote Abstracts First published: 14 June 2023 https://doi.org/10.1111/bdi.13338Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 9-10 RelatedInformation

Issue Information

Bipolar DisordersVolume 25, Issue S1 p. 1-5 ISSUE INFORMATIONFree Access Issue Information First published: 14 June 2023 https://doi.org/10.1111/bdi.13330AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 1-5 RelatedInformation

Author Index

Bipolar DisordersVolume 25, Issue S1 p. 118-126 AUTHOR INDEX Author Index First published: 14 June 2023 https://doi.org/10.1111/bdi.13363Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 118-126 RelatedInformation

ISBD Conference Steering Committee Listing.

Bipolar DisordersVolume 25, Issue S1 p. 8-8 SUPPLEMENT ARTICLE ISBD Conference Steering Committee Listing First published: 14 June 2023 https://doi.org/10.1111/bdi.13334Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume25, IssueS1Special Issue: The 25th Annual Conference of the International Society for Bipolar Disorders, Hyatt Regency Chicago, 22–25 June 2023June 2023Pages 8-8 RelatedInformation

Clinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force

BackgroundLithium has long been considered the gold-standard pharmacological treatment for the maintenance treatment of bipolar disorders (BD) which is supported by a wide body of evidence. Prior research has shown a steady decline in lithium prescriptions during the last two decades. We aim to identify potential factors explaining this decline across the world with an anonymous worldwide survey developed by the International Society for Bipolar Disorders (ISBD) Task Force “Role of Lithium in Bipolar Disorders” and distributed by diverse academic and professional international channels.ResultsA total of 886 responses were received of which 606 completed the entire questionnaire while 206 completed it partially. Respondents were from 43 different countries comprising all continents. Lithium was the most preferred treatment option for the maintenance of BD patients (59%). The most relevant clinical circumstances in which lithium was the preferred option were in patients with BD I (53%), a family history of response (18%), and a prior response during acute treatment (17%). In contrast, Lithium was not the preferred option in case of patients´ negative beliefs and/or attitudes towards lithium (13%), acute side-effects or tolerability problems (10%) and intoxication risk (8%). Clinicians were less likely to prefer lithium as a first option in BD maintenance phase when practising in developing economy countries [X2 (1, N = 430) = 9465, p = 0.002) ] and private sectors [X2 (1, N = 434) = 8191, p = 0.004)].ConclusionsClinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders appear to be affected by both the patients’ beliefs and the professional contexts where clinicians provide their services. More research involving patients is needed for identifying their attitudes toward lithium and factors affecting its use, particularly in developing economies.